ArticleTranslational oncology2019

In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity.

Lucia D'Antona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.